Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sebum suppression by benzoylperoxide.

J B Schmidt, R Neumann, R Knobler

    Dermatologica
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2024
    Same author

    Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.

    The British journal of dermatology·2020
    Same author

    Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

    The British journal of dermatology·2020
    Same journal

    Radiodermatitis with late ulcer (sarcoma) for 34 years.

    Dermatologica·2010
    Same journal

    Alopecia decalvans, totalis, maligna, with nail changes and tooth abnormalities.

    Dermatologica·2010
    Same journal

    Epidermolysis bullosa tarda simplex.

    Dermatologica·2010
    Same journal

    Blistering after psychological arousal.

    Dermatologica·2010
    Same journal

    Mycosis fungoides in the tumor stage.

    Dermatologica·2010
    Same journal

    Photoallergic rash after Irgafen.

    Dermatologica·2010
    See all related articles

    Benzoyl peroxide (BPO) treatment for acne showed varied effects on sebum excretion rate (SER). While some patients experienced a decrease in SER, the study highlights the importance of proper control groups in evaluating BPO

    Area of Science:

    • Dermatology
    • Biochemistry
    • Pharmacology

    Background:

    • Acne vulgaris is a common skin condition often treated with topical agents.
    • Benzoyl peroxide (BPO) is a widely used antimicrobial and anti-inflammatory agent for acne.
    • The effect of BPO on sebum production, a key factor in acne pathogenesis, requires further clarification.

    Purpose of the Study:

    • To investigate the impact of 10% benzoyl peroxide (BPO) on the sebum excretion rate (SER) in acne patients.
    • To evaluate the efficacy of BPO in reducing sebum production.
    • To assess the importance of control areas in studies evaluating topical acne treatments.

    Main Methods:

    • Sebum excretion rate (SER) was measured using thin-layer chromatography and densitometry.
    • 14 acne patients (9 male, 5 female) applied 10% BPO to the forehead (treatment area) for 6 weeks.

    Related Experiment Videos

  • A control area (chest) received gel vehicle only to account for systemic or non-specific effects.

    • Main Results:

    • Sebum excretion rate (SER) decreased in 10 out of 14 subjects during BPO treatment.
    • Observed SER suppression ranged from 12% to 86%.
    • Analysis considering both treatment and control areas revealed a decrease in SER in only 4 patients, indicating potential systemic or non-specific effects.

    Conclusions:

    • Topical 10% benzoyl peroxide (BPO) may influence sebum excretion rate (SER) in some acne patients.
    • The study underscores the critical need for appropriate control areas in research to accurately attribute treatment effects.
    • Further investigation is warranted to elucidate the precise mechanisms by which BPO affects sebum production.